Cookies on Venari Partners

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to recieve all cookies on the Venari Partners website. However, if you would like to, you can change your cookie settings at any time.

Our Partners

Why the US Biosimilars Market Will be slow to take off

At first glance, it appears that the US market for biosimilars is ready for takeoff In March 2015, the US Food and Drug Administration approved Zarxio from Sandoz, a biosimilar version of Amgen’s blockbuster Neupogen. Four additional biosimilar applications have been filed for FDA review.

Read More

What the US Presidential Election Means for Health Care

President-elect Donald Trump has selected two top officials who will play a key role in his health care policy. Tom Price, a vocal critic of the Affordable Care Act (ACA), has been tapped as secretary of Health and Human Services (HHS). Seema Verma, who worked with Vice President-Elect and former governor of Indiana Mike Pence to devise Indiana’s novel Medicaid policy, has been chosen to be administrator of the Centers for Medicare and Medicaid Services (CMS). These nominations signal major changes coming in US health care.

Read More

How a Digital Storm Will Disrupt the Parcel and Express Industry

It’s the year 2026, and you’ve just emerged from a tough earnings call with analysts. Revenue was down by 10%, and profits fell twice that. You tried to pin the blame on e-tailers’ price promotions for their delivery options, but the analysts didn’t buy it. They said you would just have to get used to fighting for share against these new rivals with all their momentum and tech buzz. What a comedown from the giant enterprise you remember only a decade ago. You shake your head and wonder, What happened to my industry? Digitization used to be a good thing!

Read More

Fintech in Capital Markets: A Land of Opportunity

The financial technology (fintech) phenomenon first started to evolve in the capital markets (CM) industry more than 40 years ago. Today, accelerated both by the electronification of trading in the 1990s and the subsequent thrust of the entire financial services industry toward digitization, fintechs—which we define as firms that use innovative technology at scale to either enable or compete with other financial institutions—have experienced exponential growth in the CM domain.

Read More

Get More from Medtech Innovation - Pick Your Battles

For medical technology companies, innovation is a matter of priorities. At least it should be. Today, however, when its importance is greater than ever, medtech innovation productivity is in decline.  This is not a regulatory issue. The rate of regulatory approval—in terms of 510(k) and other premarket clearances—has been relatively constant since 2011. R&D budgets have been growing by 5% per year. The problem is the declining productivity of medtech companies, which is compounded by the higher burden of proof of efficacy today’s health care systems require. Large multihospital health systems have unprecedented purchasing power; they are putting more price pressure on medtech suppliers and demanding more clinical, operational, and financial benefits of medtech products.

Read More

Transforming Media Core Technology to Meet Digital Demands

Now, it’s TV’s turn. Having reshaped the print media and music industries, digital disruption is now sweeping through the rest of media in similar fashion, rendering traditional video distribution models outmoded. The industry is rife with talk of “cutters” (consumers who drop pay TV altogether), “thinners” (those who actively manage their cable bills to pay less), and “nevers” (consumers who see no need to sign up for pay TV in the first place).

Read More

Self-Driving Vehicles, Robo-Taxis, and the Urban Mobility Revolution

It promises to be the most far-reaching advance in mobility since the invention of the automobile itself, but its biggest impact won’t be felt on the highway. Cities are where self-driving vehicles (SDVs, which are also known as autonomous vehicles) are most likely to fundamentally change—for the better—how people live, work, and, of course, get around. Far fewer accidents and much lower costs, as well as higher traffic efficiency, improved productivity, and lower pollution are just some of the anticipated benefits. Our research indicates, for example, that widespread urban adoption of SDVs and “robo-taxis” (and, especially, shared self-driving taxis) could result in a 60% drop in the number of cars on city streets, an 80% or greater decrease in tailpipe emissions, and 90% fewer road accidents.

Read More

Fixing the Medtech Commercial Model -Fixing the Medtech Commercial Model

Read More

Medtech Key Account Management in the Age of Consolidation

Read More

Travel Innovated: Who Will Own the Customer?

Consider a vision of the travel experience in the not-too-distant future. Olivia, who is 28 and lives in Seattle, decides to add a few days of pleasure travel to a business trip to Sydney. She asks Travel Dreams on the Fly, one of several new travel-concierge apps that all her friends are using, for suggestions

Read More

Page: 2